| human | Q5 |
| P6178 | Dimensions author ID | 01103006416.55 |
| P496 | ORCID iD | 0000-0001-6825-9340 |
| P69 | educated at | Osaka Medical and Pharmaceutical University | Q11440085 |
| P108 | employer | Jichi Medical University Saitama Medical Center | Q24861910 |
| P106 | occupation | researcher | Q1650915 |
| Q40116023 | A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients |
| Q87217887 | A combination of fludarabine, half-dose cyclophosphamide, and anti-thymocyte globulin is an effective conditioning regimen before allogeneic stem cell transplantation for aplastic anemia |
| Q38584425 | A retrospective analysis of computed tomography findings in patients with pulmonary complications after allogeneic hematopoietic stem cell transplantation. |
| Q40307013 | Acyclovir-resistant herpes simplex virus 1 infection early after allogeneic hematopoietic stem cell transplantation with T-cell depletion. |
| Q64124173 | Additional Cytogenetic Abnormalities with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia on Allogeneic Stem Cell Transplantation in the Tyrosine Kinase Inhibitor Era |
| Q42182292 | Allotype analysis to determine the origin of cytomegalovirus immunoglobulin-G after allogeneic stem cell transplantation |
| Q35105169 | Antibiotic prophylaxis in hematopoietic stem cell transplantation. A meta-analysis of randomized controlled trials. |
| Q52746966 | Antifungal prophylaxis with fluconazole in allogeneic stem cell transplantation recipients who had prior invasive aspergillosis with subsequent complete resolution by computed tomography. |
| Q50908224 | Assessment of the ovarian reserve with anti-Müllerian hormone in women who underwent allogeneic hematopoietic stem cell transplantation using reduced-intensity conditioning regimens or myeloablative regimens with ovarian shielding. |
| Q88003921 | Association between Activated Partial Thromboplastin Time and the Amount of Infused Heparin at Bone Marrow Transplantation |
| Q122713033 | Association between candidemia and non-infectious interstitial pneumonia after allogeneic hematopoietic cell transplantation: JSTCT Transplant Complications Working Group |
| Q96681564 | Association between the kinetics of cytomegalovirus reactivation evaluated in terms of the area under the curve of cytomegalovirus antigenemia and invasive mold infection during the post-engraftment phase after allogeneic hematopoietic stem cell tra |
| Q99205409 | Association of the areas over and under the lymphocyte curve with cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation |
| Q91254526 | Associations between febrile neutropenia-related parameters and the risk of acute GVHD or non-relapse mortality after allogeneic hematopoietic stem cell transplantation |
| Q40397260 | Clinical characteristics and predictive factors for mortality in coryneform bacteria bloodstream infection in hematological patients |
| Q39385600 | Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapy. |
| Q40342256 | Comparison of levofloxacin and garenoxacin for antibacterial prophylaxis during neutropenia. |
| Q33441641 | Delayed platelet recovery after allogeneic hematopoietic stem cell transplantation: Association with chronic graft-versus-host disease and survival outcome |
| Q92600620 | Detection of T315I using digital polymerase chain reaction in allogeneic transplant recipients with Ph-positive acute lymphoblastic anemia in the dasatinib era |
| Q40102725 | Development tuberculous meningitis during chemotherapy for CD5-positive diffuse large B-cell lymphoma |
| Q40174281 | Economic evaluation of a preemptive treatment strategy for invasive fungal infection in neutropenic patients with hematological diseases |
| Q46181753 | Effect of the duration between total body irradiation and stem cell infusion on the outcome of allogeneic transplantation with myeloablative conditioning |
| Q42208353 | Evaluation of the immune status against measles, mumps, and rubella in adult allogeneic hematopoietic stem cell transplantation recipients. |
| Q86874704 | False-positive Aspergillus galactomannan and its kinetics in allogeneic hematopoietic stem cell transplantation |
| Q112288735 | Features of repertoire diversity and gene expression in human cytotoxic T cells following allogeneic hematopoietic cell transplantation |
| Q40428384 | HLA-mismatched haploidentical transplantation using low-dose anti-thymocyte globulin (ATG: thymoglobulin). |
| Q90713674 | Haploidentical transplantation using low-dose alemtuzumab: Comparison with haploidentical transplantation using low-dose thymoglobulin |
| Q40137330 | High Incidence of Afebrile Bloodstream Infection Detected by Surveillance Blood Culture in Patients on Corticosteroid Therapy after Allogeneic Hematopoietic Stem Cell Transplantation. |
| Q41008753 | Impact of D-index and L-index on pulmonary infection in induction chemotherapy for acute lymphoblastic leukemia and lymphoblastic lymphoma |
| Q52747009 | Impact of estimated glomerular filtration rate based on plasma cystatin C and serum creatinine levels before allogeneic hematopoietic cell transplantation. |
| Q89971096 | Impact of graft-versus-host disease and graft-versus-leukemia effect based on minimal residual disease in Philadelphia chromosome-positive acute lymphoblastic leukemia |
| Q97558102 | Impact of neutropenia evaluated in terms of the D-index on invasive fungal disease while on empiric or preemptive antifungal treatment strategy in the early phase after allogeneic hematopoietic stem cell transplantation |
| Q89858045 | Impact of the patient's body weight on the efficacy and adverse events of valganciclovir for cytomegalovirus reactivation after hematopoietic stem cell transplantation |
| Q91235273 | Increased CD83 expression of CD34-positive monocytes in donors during peripheral blood stem cell mobilization in humans |
| Q91167279 | Increased Mac-2 binding protein glycan isomer in patients at risk for late nonrelapse mortality after HSCT |
| Q40922474 | Low-dose acyclovir prophylaxis for the prevention of herpes simplex virus and varicella zoster virus diseases after autologous hematopoietic stem cell transplantation |
| Q90435065 | Lower glomerular filtration rate predicts increased hepatic and mucosal toxicity in myeloma patients treated with high-dose melphalan |
| Q52915505 | Meta-analysis and meta-regression analysis to compare the outcomes of chemotherapy for T- and B-lineage acute lymphoblastic leukemia (ALL): the use of dexamethasone, L-asparaginase, and/or methotrexate may improve the outcome of T-lineage ALL. |
| Q40384599 | Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. |
| Q58593465 | Negative impact of chronic graft-versus-host disease and glucocorticoid on the recovery of physical function after allogeneic hematopoietic stem cell transplantation |
| Q88961816 | Outcome of gastrointestinal graft-versus-host disease according to the treatment response |
| Q42180502 | Persistence of recipient-derived as well as donor-derived clones of cytomegalovirus pp65-specific cytotoxic T cells long after allogeneic hematopoietic stem cell transplantation |
| Q41489633 | Pharmacokinetics study of once-daily intravenous busulfan in conditioning regimens for hematopoietic stem cell transplantation. |
| Q52763377 | Positive Cytotoxic Crossmatch Predicts Delayed Neutrophil Engraftment in Allogeneic Hematopoietic Cell Transplantation from HLA-Mismatched Related Donors. |
| Q98831018 | Pre-HCT lung computed tomography as an alternative to PFT during the COVID-19 Pandemic |
| Q42233134 | Prediction of infectious complications by the combination of plasma procalcitonin level and localized infection before allogeneic hematopoietic cell transplantation |
| Q52763314 | Pseudo-autologous stem cell transplantation for donor-derived mantle cell lymphoma 12 years after allogeneic transplantation. |
| Q44380574 | Reduced-dose (two-thirds) R-CHOP chemotherapy for elderly patients with non-Hodgkin lymphoma. |
| Q95648238 | Reduced-intensity conditioning is a reasonable alternative for Philadelphia chromosome-positive acute lymphoblastic leukemia among elderly patients who have achieved negative minimal residual disease: a report from the Adult Acute Lymphoblastic Leuk |
| Q52687295 | Refractory Graft-Versus-Host Disease-Free, Relapse-Free Survival as an Accurate and Easy-to-Calculate Endpoint to Assess the Long-Term Transplant Success. |
| Q33432975 | Risk Factors and Impact of Secondary Failure of Platelet Recovery After Allogeneic Stem Cell Transplantation |
| Q41549771 | Risk factors for pre- and post-engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation |
| Q51780256 | Safety of avoiding systemic corticosteroid administration for grade II acute graft-versus-host disease limited to the skin. |
| Q40739141 | Significance of a positive Clostridium difficile toxin test after hematopoietic stem cell transplantation |
| Q91311918 | Surgical resection for persistent localized pulmonary fungal infection prior to allogeneic hematopoietic stem cell transplantation: Analysis of six cases |
| Q92554241 | Tyrosine kinase inhibitor prophylaxis after transplant for Philadelphia chromosome-positive acute lymphoblastic leukemia |
| Q42245323 | Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells |
Search more.